{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:43:54Z","timestamp":1784889834975,"version":"3.55.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,9]]},"abstract":"<jats:p>Endoscopic biliary drainage is the recommended 1<jats:sup>st<\/jats:sup>-line treatment for malignant biliary obstruction. Although a high incidence of febrile neutropenia has been reported in patients treated with FOLFIRINOX and a biliary stent, it remains unknown whether the biliary stent contributes to patient survival. Thus, we aimed to elucidate the effects of biliary stents on the survival of patients with advanced pancreatic cancer treated with modified FOLFIRINOX (mFFX). We retrospectively reviewed medical charts of patients with advanced pancreatic cancer treated with mFFX between January 2014 and April 2020. We compared the overall survival (OS) of patients with and without biliary stent during mFFX treatment and examined the independent effect on mortality using propensity score matching. Overall, we included 89 patients (stent group, n\u2005=\u200524; non-stent group, n\u2005=\u200565). The proportion of patients with pancreatic head cancer was significantly higher in the stent group than in the non-stent group (<jats:italic toggle=\"yes\">P\u2005<\/jats:italic>&lt;\u2005.01). Stratification analysis in patients with pancreatic head cancer revealed that OS was significantly shorter in the stent group than in the non-stent group (<jats:italic toggle=\"yes\">P\u2005<\/jats:italic>=\u2005.03). After propensity score matching, 19 pairs of patients in each group were analyzed. The stent group revealed a significantly shorter survival than the non-stent group (median OS, 10.3 vs 24.9 months; <jats:italic toggle=\"yes\">P\u2005<\/jats:italic>&lt;\u2005.01). The incidences of febrile neutropenia (<jats:italic toggle=\"yes\">P\u2005<\/jats:italic>=\u2005.01) and biliary tract-related events that required biliary stenting or stent replacement (<jats:italic toggle=\"yes\">P\u2005<\/jats:italic>&lt;\u2005.01) were significantly higher in the stent group than in the non-stent group. Stent insertion was an independent risk factor for overall mortality. Biliary stents may reduce survival in patients with advanced pancreatic cancer. The rate of febrile neutropenia was higher in the stent group than in the non-stent group. There is a need to assess the patient\u2019s condition with discretion and develop a treatment strategy with short prognosis in mind after stent insertion.<\/jats:p>","DOI":"10.1097\/md.0000000000032150","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T21:31:01Z","timestamp":1673559061000},"page":"e32150","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Influence of a biliary stent in patients with advanced pancreatic cancer treated with modified FOLFIRINOX"],"prefix":"10.1097","volume":"101","author":[{"given":"Akie","family":"Yoshikawa-Kimura","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4932-508X","authenticated-orcid":false,"given":"Koichi","family":"Taira","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Abeno-ku, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Abeno-ku, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ishikawa-Kakiya","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Abeno-ku, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Yamamura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Abeno-ku, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojiro","family":"Tanoue","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Abeno-ku, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hagihara","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Osaka Metropolitan University Graduate School of Medicine, Abeno-ku, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawako","family":"Uchida-Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Osaka Metropolitan University Graduate School of Medicine, Abeno-ku, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Enomoto","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Osaka Metropolitan University Graduate School of Medicine, Abeno-ku, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Hepato-Biliary-Pancreatic Surgery, Osaka Metropolitan University Graduate School of Medicine, Abeno-ku, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Hepato-Biliary-Pancreatic Surgery, Osaka Metropolitan University Graduate School of Medicine, Abeno-ku, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Amano","sequence":"additional","affiliation":[{"name":"Department of Hepato-Biliary-Pancreatic Surgery, Osaka Metropolitan University Graduate School of Medicine, Abeno-ku, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigekazu","family":"Takemura","sequence":"additional","affiliation":[{"name":"Department of Hepato-Biliary-Pancreatic Surgery, Osaka Metropolitan University Graduate School of Medicine, Abeno-ku, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Ohfuji","sequence":"additional","affiliation":[{"name":"Department of Public Health, Osaka Metropolitan University Graduate School of Medicine, Abeno-ku, Osaka, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Abeno-ku, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Nagami","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Abeno-ku, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Abeno-ku, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00534-011-0403-8","article-title":"Preoperative biliary stents in pancreatic cancer","volume":"18","author":"Bonin","year":"2011","journal-title":"J Hepatobil Pancreat Sci"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(87)92733-4","article-title":"Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice","volume":"2","author":"Speer","year":"1987","journal-title":"Lancet"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"111346","DOI":"10.18632\/oncotarget.22795","article-title":"A multicenter prospective phase II study of first-line modified FOLFIRINOX for unresectable advanced pancreatic cancer","volume":"8","author":"Yoshida","year":"2017","journal-title":"Oncotarget"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/cas.12501","article-title":"Phase II study of FOLFIRINOX for chemotherapy-na\u00efve Japanese patients with metastatic pancreatic cancer","volume":"105","author":"Okusaka","year":"2014","journal-title":"Cancer Sci"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00280-020-04051-x","article-title":"Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancer","volume":"85","author":"Keum","year":"2020","journal-title":"Cancer Chemother Pharmacol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J Clin Oncol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00280-018-3577-9","article-title":"A phase II study of modified FOLFIRINOX for chemotherapy-na\u00efve patients with metastatic pancreatic cancer","volume":"81","author":"Ozaka","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","article-title":"Pancreatic Adenocarcinoma, Version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Tempero","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/13651820802291233","article-title":"The anatomic location of pancreatic cancer is a prognostic factor for survival","volume":"10","author":"Artinyan","year":"2008","journal-title":"HPB (Oxford)"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12876-019-0975-3","article-title":"Tumor location as an indicator of survival in T1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysis","volume":"19","author":"Meng","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"259","DOI":"10.21037\/jgo.2018.12.08","article-title":"Outcome of head compared to body and tail pancreatic cancer: a systematic review and meta-analysis of 93 studies","volume":"10","author":"Tomasello","year":"2019","journal-title":"J Gastrointest Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:46:48Z","timestamp":1746334008000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":15,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032150","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]}}}